Dentsply Sirona price target lowered to $19 from $20 at BofA

BofA lowered the firm’s price target on Dentsply Sirona (XRAY) to $19 from $20 and keeps a Neutral rating on the shares. Visibility remains “a key question,” but valuation is “relatively undemanding at current levels,” argues the analyst, who lowered the multiple applied to the firm’s estimates to reflect softer organic growth in the near-term.